Systems and methods are provided for improved optical imaging of target areas by an optical imaging visualization device, such as an endoscope, laparoscope, arthroscope, ophthalmoscope, borescope, or other remote imaging visualization technology.
Remote optical visualization devices such as endoscopes and other optical imaging visualization devices illuminate surfaces and other objects a distance from the user of the visualization device, allowing a user to perform a diagnosis or procedure using images and signals generated and transmitted a distance from the observed object. This can include, for example, viewing tissue inside a body cavity or a lumen, inspecting a hydraulic line in an aircraft, inspecting an oil pipeline for leaks, or inspecting a sewer line for leaks and/or blockages. Remote optical visualization devices transmit these images to the viewer in a variety of ways, including, among others, through the use of (i) relay lenses between the objective lens at the distal end of the scope and an eyepiece, (ii) fiber optics, and (iii) charge coupled devices (CCD) and complementary metal oxide semiconductor (CMOS) sensors. Frequently, a video capture system is connected to the optical visualization device to display a video image on a display monitor that can be viewed by a user during use of the optical visualization device, including the ability to adjust the focus of the display through manual adjustments or autofocus capability in a video processor system used with the optical imaging device. To achieve video capture with a video processor system, an objective lens of an optical visualization device focuses light reflected from a target being observed on an image sensor. The image sensor outputs signals based on the detected reflected light. The signals from the image sensor are output to a signal processor, which typically includes imaging software that controls an autofocus feature connected to the objective lens to adjust the in-focus object plane position. A control signal generated by the signal processor activates an autofocus operation to automatically bring the target being observed into focus.
Optical couplers positioned over the objective image capturing element of an optical visualization device allow improved remote observation in areas of the body where visibility has been obstructed by blood, stomach content, bowel content, or other opaque fluids and/or solid particulate matter. Optical couplers also allow improved remote observation in non-medical applications where visibility has been obstructed by fluids and/or solid particulate matter. However, imperfections on the surface of the optical coupler may inhibit the visualization of the optical visualization device, including confusing the signal processor of an optical visualization device using a video capture system, causing the autofocus feature to focus the objective lens on a surface of the optical coupler, rather than on the intended target to be observed. Further, when an optical coupler is used with visualization systems that do not use image capture software, visualization may be hindered when the light from the visualization system passes through imperfections on the distal surface of the optical coupler resulting in increased light reflection and increased glare due to these imperfections. This may occur when light proceeds through the optical coupler and when light returns back through the optical coupler to the scope camera.
It would be advantageous to provide an endoscope that allows improved remote visualization while not interfering with the autofocus feature of a video capture system and not causing increased light reflectance and glare due to improved surface finish.
Endoscopes are provided with one or more distal surfaces having a defined degree of roughness. In embodiments, a surface of the endoscope has a Root Mean Square (RMS) Roughness below about 20 nanometers, in embodiments from about 5 nanometers to about 18 nanometers. In embodiments, the surface roughness of the endoscope surface is below about 0.5 nanometers, in embodiments from about 0.1 nanometers to about 0.4 nanometers. In embodiments, a surface of the endoscope has a Root Mean Square (RMS) Roughness below about 20 nanometers with spatial frequencies between 1×10−1 mm−1 to 1×103 mm−1, in embodiments Y from about 5 nanometers to about 18 nanometers for a similar spatial frequency range.
The “surface roughness of the endoscope surface is below about 0.5 nanometers” means that one of the center-line mean roughness (Ra), the ten-point height irregularities (Rz), and the maximum height roughness (Rmax) is less than 0.5 nanometers, ±0.05 nanometers. In embodiments, a surface of the endoscope has a center-line mean roughness (Ra) of no more than about 0.5 nanometers, in embodiments, from about 0.1 nanometers to about 0.4 nanometers. In embodiments, a surface of the endoscope has a ten-point height irregularities (Rz) of no more than about 0.5 nanometers, in embodiments, from about 0.1 nanometers to about 0.4 nanometers. In embodiments, a surface of the endoscope has a maximum height roughness (Rmax) of no more than about 0.5 nanometers, in embodiments, from about 0.1 nanometers to about 0.4 nanometers. In embodiments, a surface of the endoscope has an average defect density of no more than about 100 defects per 10 μm2, in embodiments from about 10 defects per 10 μm2 to about 75 defects per 10 μm2. In embodiments, the distal surface of the endoscope has a defined degree of roughness. In embodiments, the surface of the endoscope closest to the objective lens has a defined degree of roughness.
The above and other aspects, features, and advantages of the present disclosure will become more apparent in light of the following detailed description when taken in conjunction with the accompanying drawings in which:
The figures depict specific embodiments of the present disclosure for purposes of illustration only. One skilled in the art will readily recognize from the following discussion that alternative embodiments of the structures and methods illustrated herein may be employed without departing from the principles of the present disclosure described herein.
The present endoscopes provide for improved optical imaging of surfaces covered with opaque fluids, semisolid materials or particulate matter, without interfering with the autofocus feature and other image capture and transmission elements of the optical imaging visualization device and its related system elements. These advantages are provided by ensuring that one or more surface(s) of the endoscope in the optical path has a defined degree of roughness, as described in more detail below.
The devices and methods described herein can be used in various applications. With Natural Orifice Translumenal Endoscopic Surgery (NOTES), the coupler enables procedures to continue when unexpected bleeding or other fluids such as bile or stomach contents obstruct the view. Also, the coupler can create or increase working space by pushing organs out of the field of view. With a laryngoscope in trauma and emergency situations, the coupler would push blood, foreign objects, or food away to increase visibility to allow visualizing of the trachea. When taking biopsies is required, the coupler isolates the intended biopsy target, the tumor or area to be biopsied from surrounding tissue. Close focusing and contact with the tissue with the aid of the coupler can improve reliability by allow multiple biopsies to taken in exact locations defining borders of the tumor, and minimize tumor cells from entering the blood stream or lymph channels. A cautery probe or electrode can be used simultaneously or in conjunction with the biopsy forceps, minimizing bleeding and length of procedure.
The coupler can be used in various endoscopic intra-cardiac procedures such as: (1) myocardial biopsy (for transplant monitoring or tumor sampling); (2) valve repair or reconstruction; (3) patent foramen oval (PFO) closure; (4) ventricle septal defect (VSD) closure; (5) pacing wire placement or removal; (6) stem cell injection; (7) coronary sinus cannulations (8) and maze procedure. In cryoablation, a specialized composite coupler could be made that has warming channels to warm the external surface of the coupler to protect surrounding tissue from freezing. In radiofrequency ablation, insulating and isolating properties of the coupler would concentrate power, protecting surrounding tissue.
The coupler can be used in various vascular procedures. The coupler can be used to guide proper placement of covered stents in dissected aortas, or visualize an intra-vascular laser. The coupler could be used to inspect the suture line of a large or small vessel anastomosis to evaluate the quality of the suturing and or determine the location of any bleeding.
In certain surgical or trauma situations there is severe arterial bleeding from a wound or vessel. Often the first action taken is to compress a finger or sponge on the area of bleeding. After time passes the finger or sponge is removed. If the bleeding continues either more compression or other actions are taken such as blind clamping, suctioning the blood away and then clamping and suturing, or homeostatic materials are applied. Blood loss can be substantial. An embodiment mounted at the end of a finger shaped wand can be compressed over a bleeding site, both clearing the field of blood and creating a view to locate the point of bleeding. Since the coupler is clear, soft and biocompatible, a suture or staple can be passed though the coupler to repair the bleeding site.
The working channels within the coupler or parallel to the coupler allow surgical instruments, probes, biopsy needles, needles, sutures etc. to be passed to the area being viewed. Since the coupler is flexible, the channels can move within or around the coupler without compromising its function. One enabling property of the coupler is its soft flexible shape that conforms to the tissue or object being viewed. This characteristic reduces damage to delicate tissues or structures.
Another advantage of the coupler is that only the specific area being viewed through the coupler attached to the endoscope requires illumination and therefore, the targeted view requires less light to be supplied by the endoscope lighting system. Because the number of light fibers required for illumination is less, endoscopes can be smaller or less expensive to manufacture. Also, since it is only necessary to illuminate the area of the coupler at its outer boundary, endoscopes of smaller diameter would be required to view a targeted area.
The coupler can be a semi-solid gel, which is transparent and flexible, that attaches to a wide variety of endoscopes. For minimally invasive procedures, the smallest possible scope is used. The optimal shape and size of the coupler can be determined by the field of view of the endoscope, or conversely an endoscope can be chosen that will match the size and shape of the coupler. The shape of the coupler can be manufactured with a preformed shape matched to the contour of the object that will be examined, for example an endoscope coupler could be made in the shape of the blood pool at the apex of the heart. This coupler can be used in conjunction with a 2 mm angioscope maneuvered into the apex of the heart and displace the blood to visualize the inside wall of the ventricle of the beating heart.
The coupler can be attached to the endoscope with a clear adhesive material. The coupler can be attached as a screw on auxiliary lens or filter allowing different couplers with different purposes or functions to be utilized with the same scope. The coupler can be attached and held in place with suction. The coupler can be attached by sewing on with sutures. The coupler can be attached with wire, nylon or other braid material. The coupler can be attached to endoscopes with mesh or pliable membranes. When using a mesh net to attach the coupler to the endoscope, gel strength and viscosity must be high enough to prohibit gel flow through holes in the outer layer of mesh.
A coupler can be compressed in a tube fixed to the end of the scope. A coupler attached to the endoscope can be compressed in a retractable sheath. Embodiments of the coupler can have one, two or more working channels that align with the endoscope's working lumens. Other versions of the coupler allow for additional internal channels or along the edges of the device for use in more complex procedures, such as suturing.
The coupler can be used in any minimally invasive procedure. Biopsies in the body, for example, could be taken under direct view, reducing the need for CO2 inflation. The coupler allows exact placement of needles and medical devices in situations where active bleeding or other bodily fluids impede visibility. The coupler can be held with pressure over an active bleeding site to stop bleeding until the suturing process, stapling, clamping or medical device placement is complete.
Turning now to
Optical coupler 10 also includes an attachment section 22 connected to and extending away from visualization section 12. Attachment section 22 is at the proximal end 23 of optical coupler 10. In the embodiment shm.vn, attachment section 22 is in the fom1 of a cylindrical wall 24. Proximal surface 18 and cylindrical wall 24 of optical coupler 10 define a cylindrical opening 25 of optical coupler 10 within cylindrical wall 24. In other embodiments, the optical coupler may be attached in other manners, including using a gel or glue.
Referring to
Outer surface 14 and proximal surface 18 of optical coupler 10 lie within the optical path of objective lens 40. In accordance with the present disclosure, at least one of outer surface 14 or proximal surface 18 of optical coupler 10 is provided with a defined degree of roughness. The degree of roughness is the aggregate of any textural constituent elements present on the lens. The size of the textural constituent element is not particularly limited provided the overall degree of roughness does not interfere with the visualization of the image transmitted by the image capture system associated with the endoscope onto which the optical coupler has been mounted.
In embodiments, the outer surface of the coupler transmits both the light used for illumination and the returning light used for imaging simultaneously. This common-path illumination and imaging lens allows for uniform illumination of an object near or at the focal region of the optical imaging visualization device. However because of this, any surface defects may cause light to be refracted or reflected back toward the camera and cause glare or reduced contrast. Also, even a very smooth transmitting surface will reflect a small percentage of light due to Fresnel reflections; therefore, the figure and location of the lens surface must be controlled such that light emitted from the illumination source will not reflect as such angles as to cause unwanted glare along with the surface finish with a defined degree of roughness.
In embodiments, the length and the width of any given textural constituent element can both be 10 μm or less. In embodiments, the length of the textural constituent element (size of the textural constituent element in the longer direction) is 3 μm or less and the width (size of the textural constituent element in the shorter direction) 500 nm or less. In other embodiments, the length and the width of the textural constituent element are preferably in the range of 3 μm to 50 nm. In embodiments, the depth of the textural constituent element may be 15 nm to 200 nm.
In embodiments where outer surface 14 or proximal surface 18 of optical coupler 10 includes depressions, the depressions have an average diameter less than 100 nanometers, in embodiments, from about 15 to about 50 nanometers. The depressions may have an average depth less than about 100 nanometers, in embodiments from about 4 nanometers to about 50. The depressions may have a density or an average density, meaning the number of depressions per 100 square micrometers of surface or the average number of depressions per 100 square micrometers of surface, of less than about 100 depressions per 100 square micrometers of surface, in embodiments from about 15 to about 50 depressions per 100 square micrometers of surface.
In embodiments, a surface of the optical coupler has a Root Mean Square (RMS) Roughness below about 200 Angstroms; in embodiments, from about 50 Angstroms to about 180 Angstroms. In embodiments, the surface roughness of the optical coupler surface is below about 0.5 nanometers, in embodiments from about 0.1 nanometers to about 0.4 nanometers. The “surface roughness of the optical coupler surface is below about 0.5 nanometers” means that one of the center-line mean roughness (Ra), the ten-point height irregularities (Rz), and the maximum height roughness (Rmax) is less than 0.5 nanometers, ±0.05 nanometers. In embodiments, a surface of the optical coupler has a center-line mean roughness (Ra) of no more than about 0.5 nanometers, in embodiments, from about 0.1 nanometers to about 0.4 nanometers. Tn embodiments, a surface of the optical coupler has a ten-point height irregularities (Rx) of no more than about 0.5 nanometers, in embodiments, from about 0.1 nanometers to about 0.4 nanometers. In embodiments, a surface of the optical coupler has a maximum height roughness (Rmax) of no more than about 0.5 nanometers, in embodiments, from about 0.1 nanometers to about 0.4 nanometers. In embodiments, a surface of the optical coupler has an average defect density of no more than about 100 defects per 10 μm2, in embodiments from about 10 defects per 10 μm2 to about 75 defects per 10 μm2. In embodiments, outer surface 14 of optical coupler 10 has a defined degree of roughness. In embodiments, proximal surface 18 of optical coupler 10 (i.e., the surface closest to the objective lens of the endoscope) has a defined degree of roughness.
The degree of roughness can be determined by using any technique within the purview of those skilled in the art, such as, for example, a laser surface analyzer or a stylus surface profiler, but it can also be determined, simply by direct observation of the surface and cross section under SEM.
A defined degree of roughness is provided on a surface of the optical coupler using techniques within the purview of those skilled in the art. The specific method chosen will depend on a number of factors including the material from which the optical coupler is made.
Optical coupler 10 can be formed from a variety of materials exhibiting transparency or translucency and biocompatibility in medical applications. In embodiments, an optical coupler for non-medical applications can be formed from a variety of materials exhibiting transparency or translucency.
In embodiments, a rigid material, e.g., a resin material such as cycloolefin polymer or polycarbonate, is used to form the optical coupler. When rigid materials are used, they are typically molded and then one or more surface is polished to impart a defined degree of roughness. Polishing techniques are within the purview of those skilled in the art and include, for example, chemical-mechanical polishing, mechanical polishing, CMP processes, reactive ion etching (e.g., with a substantially chemically etching component), physical etching, and wet etching.
In embodiments, a flexible material is used to form the optical coupler. Flexible materials are typically difficult to polish. Accordingly, where flexible materials are used, a defined degree of roughness is provided on the surface of a mold and imparted to the optical coupler when it is molded.
In embodiments, the mold is prepared by any technique within the purview of those skilled in the art, such as for example, the use of a series of micropolish compounds to prepare and refine the finish of the mold to the point where the mold can produce an optical coupler with the desired surface finish on the optical coupler, and, alternatively, creating the mold using single-point diamond turning to cut the surface of the mold with a level of refined surface that the mold produces an optical coupler with the desired surface finish on the optical coupler.
In embodiments, optical coupler 10 is molded from a material selected from glass, silicone gels, silicone elastomers, epoxies, polyurethanes, polycarbonates, acrylics, other elastic materials, and mixtures thereof. The silicone gels can be lightly cross-linked polysiloxane (e.g., polydimethylsiloxane) fluids, where the cross-link is introduced through a multifunctional silane. The silicone elastomers can be cross-linked fluids whose three-dimensional structure is much more intricate than a gel as there is very little free fluid in the matrix. In other embodiments, optical coupler 10 is made from a material selected from hydrogels, such as polyvinyl alcohol, poly(hydroxyethyl methacrylate), polyethylene glycol, poly(methacrylic acid), and mixtures thereof. The material for optical coupler 10 may also be selected from albumin based gels, mineral oil based gels, polyisoprene, or polybutadiene. In embodiments, the material is viscoelastic.
In embodiments, the optical coupler is a clear gel attached to the outer distal portion of any optical imaging or image capturing device, such as an endoscope or camera lens. When pressed in contact with the surface of an area to be viewed, the gel creates an offset that allows clear visualization by mechanically displacing the opaque liquid or soft semisolids.
The material used to form the optical coupler can be comprised of two or more compounds, for example an opaque compound attaches and holds two visualization portions of a coupler in position, the first visualization portion is an inner clear semi rigid compound shaped to match the field of view and minimum depth field of the imaging system, and the second portion is attached to the outer boundary of the first visualization portion and is composed of very soft gel providing additional area of fluid displacement for maneuvering and positioning instruments under direct vision. In embodiments, the two or more compounds each can be of materials that exhibit transparency or translucency. Methods described in U.S. Pat. Nos. 7,235,592 and 7,205,339 can be utilized to produce a coupler with portions or areas of the gel with different physical properties.
Referring back to
The optical coupler 10 may also be coated. Coating may reduce the amount of adherence properties and/or reduce unwanted light reflections, and/or change and enhance the optical coupler by adding hydrophobic or hydrophilic properties. Suitable coatings that may be used on the optical coupler include, but are not limited to, polymers based on p-xylylene, such as for example, polymers that are commercially available under the trade name Parylene C, which is an optically clear biocompatible polymer having abrasion resistant and hydrophobic or hydrophilic properties.
The following Examples have been presented in order to further illustrate the devices and methods described herein and are not intended to limit the invention(s) in any way.
A series of optical couplers in a shape similar to that of FTG. 3 was molded from Nusil MED-6033 an optical grade liquid silicone elastomer available from Nusil Technologies, Carpinteria, California. This silicone has an index of refraction of 1.41, and a durometer of about 45 on the Shore 00 scale. The surface of the mold forming the outer surface of the optical coupler was manufactured using a micropolishing methodology to impart a surface finish better than the Society of Plastic Industry (SP1) Al finish on to the mold. The surface finish of the mold and the resulting lenses were measured using a Zygo interferometer to determine the surface finish on the distal surface of the optical coupler.
These optical couplers were then placed on a number of scopes, including an Olympus CF-Q160A/L colonoscope, a 10 mm rigid laparoscope and a Pentax EG-2990 gastroscope. The visual performance of these optical couplers was observed to determine the impact of surface finish on the visual performance of these scopes without an optical coupler and with an optical coupler. and the following was noted: The lenses measured with this approach had the following attributes:
To further assess the variations in the surface finish of the optical couplers, assessments were performed by placing the couplers on the scopes mentioned above and moving various targets in close and away from the endoscope, at specific distances ranging from 3 mm out to several centimeters to assess how changes in light and object distance impact optical performance, relative to surface finish. In addition, the optical couplers were tested at these various distances in situations involving fluid and debris to determine the impact of various levels of surface finish and various distances and environments on visual performance. The performance of these optical couplers was compared to the performance of a scope without the optical coupler to determine an acceptable surface finish that did not interfere with the capture of the visual image through the optical coupler.
As can be seen from the data in Table A, a surface roughness of less than 12.7432 nm RMS did not interfere with the video capture and autofocus software, while surface roughness in excess of this level of surface roughness confused the software, and caused the image of target tissue displayed by the endoscope to be intemlittently out of focus. Further, when lenses were tested on scopes without imaging software, the glare and reflection was unacceptably high, inhibiting performance, at the surface roughness greater than 12.7432 nm RMS.
Persons skilled in the art will understand that the devices and methods specifically described herein and illustrated in the accompanying drawings are non-limiting exemplary embodiments. The features illustrated or described in connection with one exemplary embodiment may be combined with the features of other embodiments. Such modifications and variations are intended to be included within the scope of the present disclosure. As well, one skilled in the art will appreciate further features and advantages of the present disclosure based on the above-described embodiments. Accordingly, the present disclosure is not to be limited by what has been particularly shown and described, except as indicated by the appended claims.
It should be understood that the foregoing description is only illustrative of the present disclosure. Various alternatives and modifications can be devised by those skilled in the art without departing from the disclosure. For example, the coupler may be used in non-medical applications wherein the coupler is attached to the distal end of a borescope or attached to micro, conventional, or robotic video cameras, inspection scopes, or still cameras, thereby allowing viewing and/or making repairs inside pipes, holding tanks, containers, etc. without the need to empty the pipes or containers of static or moving opaque fluid, such as petroleum products, sewerage, food products, paint, etc. In non-medical, industrial applications, the coupler can be formed from materials that resist acid, alkalinity, high heat, or viscosity of fluid being displaced by the coupler and may be reusable. Accordingly, the present disclosure is intended to embrace all such alternatives, modifications and variances. The embodiments described with reference to the attached drawing figures are presented only to demonstrate certain examples of the disclosure. Other elements, steps, methods and techniques that are insubstantially different from those described above and/or in the appended claims are also intended to be within the scope of the disclosure.
This application is a continuation of U.S. patent application Ser. No. 17/206,119, filed Mar. 19, 2021, which is a continuation of U.S. patent application Ser. No. 16/828,134, filed Mar. 24, 2020 (now U.S. Pat. No. 10,989,912), which is a continuation of U.S. patent application Ser. No. 16/161,312, filed Oct. 16, 2018 (now U.S. Pat. No. 10,642,020), which is a continuation of U.S. patent application Ser. No. 15/653,437, filed Jul. 18, 2017 (now U.S. Pat. No. 10,101,574), which is a continuation of U.S. patent application Ser. No. 15/259,452, filed Sep. 8, 2016 (now U.S. Pat. No. 9,709,795), which is a continuation of U.S. patent application Ser. No. 14/494,090, filed Sep. 23, 2014 (now U.S. Pat. No. 9,459,442) the entire disclosures of which are incorporated herein by reference for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
3774614 | Cook | Nov 1973 | A |
3858577 | Bass et al. | Jan 1975 | A |
4090501 | Chaitin | May 1978 | A |
4201199 | Smith | May 1980 | A |
4207872 | Meiri et al. | Jun 1980 | A |
4340811 | Yamashita et al. | Jul 1982 | A |
4681093 | Ono et al. | Jul 1987 | A |
4696544 | Costella | Sep 1987 | A |
4744620 | Ueno et al. | May 1988 | A |
4779611 | Grooters et al. | Oct 1988 | A |
4805598 | Ueda | Feb 1989 | A |
4878725 | Hessel et al. | Nov 1989 | A |
4881810 | Hasegawa | Nov 1989 | A |
4888243 | Jonas et al. | Dec 1989 | A |
4967732 | Inoue | Nov 1990 | A |
5040715 | Green et al. | Aug 1991 | A |
5050585 | Takahashi | Sep 1991 | A |
5080660 | Buelna | Jan 1992 | A |
5104025 | Main et al. | Apr 1992 | A |
5137198 | Nobis et al. | Aug 1992 | A |
5201900 | Nardella | Apr 1993 | A |
5205459 | Brinkerhoff et al. | Apr 1993 | A |
5237984 | Williams, III et al. | Aug 1993 | A |
5271379 | Phan et al. | Dec 1993 | A |
5326013 | Green et al. | Jul 1994 | A |
5329935 | Takahashi | Jul 1994 | A |
5337734 | Saab | Aug 1994 | A |
5342388 | Toller | Aug 1994 | A |
5413052 | Breezer et al. | May 1995 | A |
5413268 | Green et al. | May 1995 | A |
5443781 | Saab | Aug 1995 | A |
5448990 | De Faria-Correa | Sep 1995 | A |
5460168 | Masubuchi et al. | Oct 1995 | A |
5471036 | Sperbeck | Nov 1995 | A |
5476206 | Green et al. | Dec 1995 | A |
5536236 | Yabe et al. | Jul 1996 | A |
5555129 | Konno et al. | Sep 1996 | A |
5562602 | Yabe et al. | Oct 1996 | A |
5569157 | Nakazawa et al. | Oct 1996 | A |
5575291 | Hayakawa et al. | Nov 1996 | A |
5605532 | Schermerhorn | Feb 1997 | A |
5632717 | Yoon | May 1997 | A |
5657921 | Young et al. | Aug 1997 | A |
5662258 | Knodel et al. | Sep 1997 | A |
5674181 | Iida | Oct 1997 | A |
5707342 | Tanaka | Jan 1998 | A |
5725474 | Yasui et al. | Mar 1998 | A |
5725475 | Yasui et al. | Mar 1998 | A |
5738629 | Moll et al. | Apr 1998 | A |
5743851 | Moll et al. | Apr 1998 | A |
5771327 | Bar-Or et al. | Jun 1998 | A |
5788628 | Matsuno et al. | Aug 1998 | A |
5808813 | Lucey et al. | Sep 1998 | A |
5840014 | Miyano et al. | Nov 1998 | A |
5860913 | Yamaya et al. | Jan 1999 | A |
5897487 | Ouchi | Apr 1999 | A |
5916148 | Tsuyuki | Jun 1999 | A |
6059719 | Yamamoto et al. | May 2000 | A |
6131789 | Schulze et al. | Oct 2000 | A |
6217509 | Foley et al. | Apr 2001 | B1 |
6250532 | Green et al. | Jun 2001 | B1 |
6277065 | Donofrio | Aug 2001 | B1 |
6283951 | Flaherty et al. | Sep 2001 | B1 |
6293907 | Axon et al. | Sep 2001 | B1 |
6306081 | Ishikawa et al. | Oct 2001 | B1 |
6409725 | Khandkar et al. | Jun 2002 | B1 |
6416462 | Tovey et al. | Jul 2002 | B1 |
6673091 | Shaffer et al. | Jan 2004 | B1 |
6699180 | Kobayashi | Mar 2004 | B2 |
6712524 | Beatty et al. | Mar 2004 | B2 |
6723350 | Burrell et al. | Apr 2004 | B2 |
6733440 | Ailinger et al. | May 2004 | B2 |
6770069 | Hobart et al. | Aug 2004 | B1 |
6792837 | Battistone | Sep 2004 | B2 |
6855108 | Ishibiki et al. | Feb 2005 | B2 |
6866627 | Nozue | Mar 2005 | B2 |
6934093 | Kislev et al. | Aug 2005 | B2 |
6981628 | Wales | Jan 2006 | B2 |
6988650 | Schwemberger et al. | Jan 2006 | B2 |
7033317 | Pruitt | Apr 2006 | B2 |
7046439 | Kaminsky et al. | May 2006 | B2 |
7087012 | Ishibiki | Aug 2006 | B2 |
7112195 | Boll et al. | Sep 2006 | B2 |
7205339 | Muratoglu | Apr 2007 | B2 |
7235592 | Muratoglu et al. | Jun 2007 | B2 |
7238153 | Moriyama | Jul 2007 | B2 |
7245813 | Brown et al. | Jul 2007 | B2 |
7464847 | Viola et al. | Dec 2008 | B2 |
7537561 | Yamaya et al. | May 2009 | B2 |
7553278 | Kucklick | Jun 2009 | B2 |
7554743 | Jiang et al. | Jun 2009 | B2 |
7566993 | May | Jul 2009 | B2 |
7621868 | Breidenthal et al. | Nov 2009 | B2 |
7819872 | Johnson et al. | Oct 2010 | B2 |
7977255 | Scheer et al. | Jul 2011 | B1 |
8180423 | Mang et al. | May 2012 | B2 |
8905921 | Titus | Dec 2014 | B2 |
8915931 | Boudreaux et al. | Dec 2014 | B2 |
9011320 | Weitzner et al. | Apr 2015 | B2 |
9459442 | Miller | Oct 2016 | B2 |
9565991 | Yamada | Feb 2017 | B2 |
9709795 | Miller | Jul 2017 | B2 |
10101574 | Miller | Oct 2018 | B2 |
10642020 | Miller | May 2020 | B2 |
10989912 | Miller | Apr 2021 | B2 |
11428922 | Miller | Aug 2022 | B2 |
20020035311 | Ouchi | Mar 2002 | A1 |
20020065515 | Falwell et al. | May 2002 | A1 |
20020133148 | Daniel et al. | Sep 2002 | A1 |
20030040657 | Yamaya et al. | Feb 2003 | A1 |
20030181900 | Long | Sep 2003 | A1 |
20040157073 | Burrell et al. | Aug 2004 | A1 |
20040249246 | Campos | Dec 2004 | A1 |
20040263613 | Morita | Dec 2004 | A1 |
20040267092 | Ishibiki | Dec 2004 | A1 |
20050043589 | Pruitt | Feb 2005 | A1 |
20050080411 | Ouchi | Apr 2005 | A1 |
20050131279 | Boulais et al. | Jun 2005 | A1 |
20050197530 | Wallace et al. | Sep 2005 | A1 |
20060030844 | Knight et al. | Feb 2006 | A1 |
20060084839 | Mourlas et al. | Apr 2006 | A1 |
20060173241 | Ouchi et al. | Aug 2006 | A1 |
20060200176 | Matsuno et al. | Sep 2006 | A1 |
20060229662 | Finkielsztein et al. | Oct 2006 | A1 |
20060270900 | Chin et al. | Nov 2006 | A1 |
20070038043 | Gelikonov et al. | Feb 2007 | A1 |
20070066869 | Hoffman | Mar 2007 | A1 |
20070066870 | Ohashi et al. | Mar 2007 | A1 |
20070073108 | Takahashi | Mar 2007 | A1 |
20070208219 | Carter | Sep 2007 | A1 |
20070239620 | Schwartz et al. | Oct 2007 | A1 |
20070260117 | Zwolinski et al. | Nov 2007 | A1 |
20070282256 | Hu et al. | Dec 2007 | A1 |
20070293888 | Harren et al. | Dec 2007 | A1 |
20080021268 | Shoroji et al. | Jan 2008 | A1 |
20080021269 | Tinkham et al. | Jan 2008 | A1 |
20080033246 | Matsui et al. | Feb 2008 | A1 |
20080139885 | Knapp | Jun 2008 | A1 |
20080188874 | Henderson | Aug 2008 | A1 |
20080262295 | Kendale et al. | Oct 2008 | A1 |
20080306335 | Lau et al. | Dec 2008 | A1 |
20090048483 | Yamamoto | Feb 2009 | A1 |
20090048486 | Surti | Feb 2009 | A1 |
20090062790 | Malchano et al. | Mar 2009 | A1 |
20090098409 | Yamada et al. | Apr 2009 | A1 |
20090143643 | Weitzner et al. | Jun 2009 | A1 |
20090156898 | Ichimura | Jun 2009 | A1 |
20090254164 | Johnson et al. | Oct 2009 | A1 |
20090264154 | Rofougaran | Oct 2009 | A1 |
20090315989 | Adelson | Dec 2009 | A1 |
20090326328 | Kucklick | Dec 2009 | A1 |
20100026940 | Takegami et al. | Feb 2010 | A1 |
20100121442 | Shea et al. | May 2010 | A1 |
20100203454 | Brongersma et al. | Aug 2010 | A1 |
20100268027 | Aono et al. | Oct 2010 | A1 |
20100286475 | Robertson | Nov 2010 | A1 |
20110124960 | St. Onge et al. | May 2011 | A1 |
20110152618 | Surti | Jun 2011 | A1 |
20120034573 | Erdmann et al. | Feb 2012 | A1 |
20120209074 | Titus | Aug 2012 | A1 |
20120209090 | Goodall et al. | Aug 2012 | A1 |
20120232342 | Reydel | Sep 2012 | A1 |
20130040516 | Pruneri et al. | Feb 2013 | A1 |
20130046138 | McLawhorn | Mar 2013 | A1 |
20130090527 | Axon | Apr 2013 | A1 |
20130144287 | Crowley et al. | Jun 2013 | A1 |
20130190562 | Smith et al. | Jul 2013 | A1 |
20130237998 | Wallace et al. | Sep 2013 | A1 |
20150073214 | Ueda | Mar 2015 | A1 |
20160051135 | Greenberg et al. | Feb 2016 | A1 |
20160270636 | Iwasaka et al. | Sep 2016 | A1 |
20170066111 | Wang | Mar 2017 | A1 |
20170311789 | Mulcahey et al. | Nov 2017 | A1 |
20200100655 | Morishima et al. | Apr 2020 | A1 |
Number | Date | Country |
---|---|---|
1692872 | Nov 2011 | CN |
3532609 | Mar 1987 | DE |
1870018 | Dec 2007 | EP |
H0373168 | Mar 1991 | JP |
07-178094 | Jul 1995 | JP |
H09238893 | Sep 1997 | JP |
05-123288 | May 1999 | JP |
2000300570 | Oct 2000 | JP |
3124079 | Jan 2001 | JP |
2002233491 | Aug 2002 | JP |
2003033319 | Feb 2003 | JP |
2003339631 | Dec 2003 | JP |
2005066139 | Mar 2005 | JP |
2006026344 | Feb 2006 | JP |
2008-029384 | Feb 2008 | JP |
2009261830 | Nov 2009 | JP |
5854805 | Feb 2016 | JP |
WO 9929362 | Jun 1999 | WO |
WO 2001085319 | Nov 2001 | WO |
WO 2006138409 | Dec 2006 | WO |
WO 2007029230 | Mar 2007 | WO |
WO 2007029814 | Mar 2007 | WO |
WO 2007147060 | Dec 2007 | WO |
WO 2009149042 | Dec 2009 | WO |
WO 2011085319 | Jul 2011 | WO |
WO 2011099329 | Aug 2011 | WO |
WO 2011148172 | Dec 2011 | WO |
WO 2014123563 | Aug 2014 | WO |
WO 2017011535 | Jan 2017 | WO |
Entry |
---|
European Examination Report for EP Appl. No. 15843356.5 dated May 20, 2019, 7 pages. |
Extended European Search Report for EP Appl. No. 16828548.4 dated Feb. 28, 2019. |
Extended European Search Report for EP Appl. No. 16804476.6 dated Dec. 5, 2018. |
Extended European Search Report and Written Opinion for EP Appl. No. 16804462-6 dated Dec. 10, 2018. |
Extended European Search Report for EP Appl. No. 12747511.9 dated Jan. 3, 2018. |
Extended European Search Report for EP Appl. No. 18174913.6 dated Aug. 16, 2019. |
International Preliminary Report on Patentability issued in PCT/US2015/051662 dated Apr. 6, 2017. |
International Search Report and Written Opinion for PCT Appl. No. PCT/US2019/012448 dated Apr. 16, 2019. |
International Search Report and Written Opinion dated Oct. 26, 2016 for PCT Application No. PCT/US2016/043371, filed Jul. 21, 2016. |
International Search Report issued in corresponding International Application No. PCT/US2015/051662 dated Dec. 14, 2015. |
International Search Report and Written Opinion dated Sep. 21, 2012 for PCT Appl. No. PCT/US2012/025404. |
Japanese Patent Office, Notification of Reasons for Refusal, JP Appl. No. 2013-554596, dated Dec. 8, 2015. |
Chinese Office Action and Search Report for CN Appl. No. 201280014363, dated Mar. 23, 2015. |
Chinese Office Action for CN Appl. No. 201280014363, dated Jan. 5, 2016. |
Chinese Office Action for CN Appl. No. 201680045602.6 dated Jun. 5, 2019. |
First Examination Report for Indian Appl. No. 6566/CHENP/2013 dated Aug. 29, 2019. |
Beneq Biocompatible Coatings Webpage. |
Cargille Laboratories, Inc. Material Safety Data Sheet—Cargille Optical Gel Code 0607, Jun. 3, 2005. |
Depth of Field, OPMI Application Tip #2, Informed for Medical Professionals in Neuro, ENT and Spine, 2nd Issue, Oct. 2006, Published by Carl Zeiss Surgical GmbH, Germany. |
Jaxton, et al., An Experimental Investigation on the Development of Hydrogels for Optical Applications, Polymer Testing, 2003, 22(4):371-374, English Abstract. |
Kopp, et al., Chapter 9, Optical Principles of the Endoscope, Hysteroscopy: Visual Perspectives of Uterine Anatomy, Physiology & Pathology, 3rd Edition, Lippincott Williams & Wilkins, 2007, 19 pages. |
Maquet Training Manual, Vasoview 6 Endoscopic Vessel Harvesting System, Cardiovascular, Copyright Maquet Cardiovascular LLC, Oct. 2008. |
Oil Immersion, From Wikipedia, http://en.wikipedia.org/wiki/Oil.sub.--immerson, Printed Sep. 7, 2010. |
Olympus Colonoscopes Outpatient Doctor Surgery Center, http://outpatientsurgicare.com/index.PHP?Facilities: Technologies:Olympus.sub.--Colonoscopes&print, Printed Oct. 26, 2010. |
Olympus Disposal Distal Attachment Product Data Sheet. |
Olympus Evis Exera Colonovideoscope/Sigmoidovideoscope, Olympus CF Type Q1601JUS, Today's Most Versatile Choice for Colonoscopy, Product Data Sheet. |
Olympus Technologies Evis Exera II, Learn About Wide—Angle, http://www.olympusamerica.com/msg.sub.--section/ msg.sub.--endoscopy.sub.-- -technology.asp, Copyright 2010 Olympus America Inc. |
Olympus Technologies Evis Exera II, Learn About Close Focus, http://www.olympusamerica.com/msg.sub.--section/ msg.sub.--endoscopy.sub.-- -technology.asp, Copyright 2010 Olympus America Inc. |
Olympus NA-11J-KB Product Data Sheet. |
Optical Gels for Fiber-Optic Connectors and Splices—A Tutorial, Nye Optical Products, 6 pages. |
Paxton, et al., An Experimental Investigation on the Development of Hydrogels for Optical Applications, Polymer Testing, 2003, 22(4):371-374, English Abstract. |
Sigma-Aldrich Poly(2-hydroxyethyl methacrylate) Product Data Sheet, http://www.sigmaaldrich.com/catalog/Product Detail, Copyright 2010 Sigma-Aldrich Co. |
Sigma-Aldrich Poly(ethylene glycol) Product Data Sheet, http://www.sigmaaldrich.com/catalog/Product Detail, Copyright 2010 Sigma-Aldrich Co. |
Sigma-Aldrich Poly(vinyl alcohol) Product Data Sheet, http://www.sigmaaldrich.com/catalog/Product Detail, Copyright 2010 Sigma-Aldrich Co. |
Sigma-Aldrich Methacrylic acid Product Data Sheet, http://www.sigmaaldrich.com/catalog/Product Detail, Printed Sep. 3, 2010. |
SmartGel Nye Nyogel OCK-451LPH Product Data Sheet, Nye Optical Products. |
Smeds, et al., Photocrosslinkable Polysaccharides for in situ Hydrogel Formation, Journal of Biomedical Materials Research, 2001, 54:115-121. |
Stadler, Transparent conducting oxides—An up-to-date overview, Materials 5.4:661-683, 2012. |
The Basics of Silicon Chemistry, Basic Silicon Production and Siloxane Polymerization, http://www.dowcorning.com/ content/sitech/sitechbasics/siloxane.sub.--poly- merization.asp, Copyright 2000-2010 Dow Corning Corporation. |
Uw Eye Research Institute, Newsletter, Point of View, Summer 2009, http://vision.wisc.edu/news.sub.--sum09.html, Printed Feb. 5, 2010. |
Vinyl Sustainability Forum 2014, Title: Benefits of PVC, Date retrieved: Mar. 7, 2014 from website: http://www.pvc.org/ en/p/benefits-of-pvc, pp. 1-4. |
Zeng, et al., An Endoscope Utilizing Tunable-Focus Microlenses Actuated through Infrared Light, Solid-State Sensors, Actuators and Microsystems Conference, 2009, Transducers 2009, International, Issue 21-25, pp. 1214-1217, Abstract Only. |
Zeng, et al., Tunable Liquid Microlens Actuated by Infrared Light-Responsive Hydrogel, Applied Physics Letters, 2008, 93:151101-1-151101-3. |
US Patent and Trademark Office; Office Action issued in U.S. Appl. No. 16/828,134, dated Oct. 30, 2020. |
Chinese Office Action for Chinese Patent Application No. 201680054885.0 dated Jun. 3, 2020. |
Chinese Office Action for CN Appl. No. 20168004557.9 dated Mar. 24, 2020. |
Number | Date | Country | |
---|---|---|---|
20220365333 A1 | Nov 2022 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17206119 | Mar 2021 | US |
Child | 17870896 | US | |
Parent | 16828134 | Mar 2020 | US |
Child | 17206119 | US | |
Parent | 16161312 | Oct 2018 | US |
Child | 16828134 | US | |
Parent | 15653437 | Jul 2017 | US |
Child | 16161312 | US | |
Parent | 15259452 | Sep 2016 | US |
Child | 15653437 | US | |
Parent | 14494090 | Sep 2014 | US |
Child | 15259452 | US |